Investigational drug · Phase 2
EI-1071
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Mild, Moderate, or Severe Alzheimer's Disease.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
3
Any phase or sponsor naming "EI-1071"
First trial start
2024
Dec 16, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "EI-1071", any sponsor or status.
Conditions studied
As listed on its trial records.
- Mild, Moderate, or Severe Alzheimer's Disease
Approved drugs for the same conditions: Alzheimer's disease · Neurology
Largest trials
Live from ClinicalTrials.gov: studies naming "EI-1071" as an intervention, largest first.
- A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy VolunteersCompleted
Elixiron Immunotherapeutics Inc.Industry
NCT04238364 · 58 participants · Start Dec 27, 2019 · Primary completion Dec 16, 2021
Drug: EI-1071; Placebo · For: Healthy Volunteers
Sites: Baltimore, Maryland
Elixiron Immunotherapeutics Inc.Industry
NCT07903337 · 25 participants (planned) · Start Nov 2026 · Primary completion Aug 2027
Drug: EI-1071 · For: Food Effect in Healthy Volunteers
Sites: Taipei, Taiwan
Elixiron Immunotherapeutics Inc.Industry
NCT06745583 · 7 participants · Start Dec 16, 2024 · Primary completion Mar 6, 2026
Drug: EI-1071 tablet, oral · For: Mild, Moderate, or Severe Alzheimer's Disease
Sites: Taipei, Taiwan · 2 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.